Publications

2010

Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. Curr Oncol Rep. 2010;12(6):383-94.
Rand JH. A snappy new concept for APS. Blood. 2010;116(8):1193-4.
Fiorentino M, Judson G, Penney K, Flavin R, Stark J, Fiore C, et al. Immunohistochemical expression of BRCA1 and lethal prostate cancer. Cancer Res. 2010;70(8):3136-9.
Seidman JD, Yemelyanova AV, Khedmati F, Bidus MA, Dainty L, Boice CR, et al. Prognostic factors for stage I ovarian carcinoma. Int J Gynecol Pathol. 2010;29(1):1-7.
Afaneh C, Muthukumar T, Lubetzky M, Ding R, Snopkowski C, Sharma VK, et al. Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation. 2010;90(12):1381-7.
Loda M, Kaelin WG. Prostate cancer: beta control your hormones. Cancer Cell. 2010;17(4):311-2.
Piccaluga PP, Gazzola A, Mannu C, Agostinelli C, Bacci F, Sabattini E, et al. Pathobiology of anaplastic large cell lymphoma. Adv Hematol. 2010:345053.
Triantafyllopoulou A, Franzke C-, Seshan SV, Perino G, Kalliolias GD, Ramanujam M, et al. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A. 2010;107(7):3012-7.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700